ITMI20010555A1 - Ceppo attenuato di salmonella gallinarum-pullorum e vaccino che lo contiene - Google Patents
Ceppo attenuato di salmonella gallinarum-pullorum e vaccino che lo contiene Download PDFInfo
- Publication number
- ITMI20010555A1 ITMI20010555A1 ITMI20010555A ITMI20010555A1 IT MI20010555 A1 ITMI20010555 A1 IT MI20010555A1 IT MI20010555 A ITMI20010555 A IT MI20010555A IT MI20010555 A1 ITMI20010555 A1 IT MI20010555A1
- Authority
- IT
- Italy
- Prior art keywords
- pullorum
- strain
- salmonella
- vaccine
- salmonella gallinarum
- Prior art date
Links
- 241000607142 Salmonella Species 0.000 title claims description 16
- 229960005486 vaccine Drugs 0.000 title claims description 16
- 238000000034 method Methods 0.000 claims description 10
- 241000271566 Aves Species 0.000 claims description 8
- 206010057249 Phagocytosis Diseases 0.000 claims description 8
- 230000008782 phagocytosis Effects 0.000 claims description 8
- 238000002255 vaccination Methods 0.000 claims description 7
- 210000003714 granulocyte Anatomy 0.000 claims description 5
- 241000287828 Gallus gallus Species 0.000 claims description 4
- 206010039438 Salmonella Infections Diseases 0.000 claims description 4
- 235000013330 chicken meat Nutrition 0.000 claims description 4
- 206010039447 salmonellosis Diseases 0.000 claims description 4
- 230000001018 virulence Effects 0.000 claims description 3
- 229940031551 inactivated vaccine Drugs 0.000 claims 1
- 230000006698 induction Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 description 6
- 230000002238 attenuated effect Effects 0.000 description 5
- 239000013049 sediment Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 229940124590 live attenuated vaccine Drugs 0.000 description 4
- 229940023012 live-attenuated vaccine Drugs 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 206010040047 Sepsis Diseases 0.000 description 3
- 230000000680 avirulence Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 208000013223 septicemia Diseases 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 208000004232 Enteritis Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000006150 trypticase soy agar Substances 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- 241000596091 Salmonella enterica subsp. enterica serovar Anatum Species 0.000 description 1
- 241000392514 Salmonella enterica subsp. enterica serovar Dublin Species 0.000 description 1
- 241000607726 Salmonella enterica subsp. enterica serovar Heidelberg Species 0.000 description 1
- 241000210647 Salmonella enterica subsp. enterica serovar Montevideo Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 230000005571 horizontal transmission Effects 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI20010555 ITMI20010555A1 (it) | 2001-03-16 | 2001-03-16 | Ceppo attenuato di salmonella gallinarum-pullorum e vaccino che lo contiene |
| TR2002/00659A TR200200659A3 (tr) | 2001-03-16 | 2002-03-13 | Salmonella gallinarum-pullorum zayiflatilmis türü ve bunlari içeren asi. |
| HU0200984A HU226257B1 (en) | 2001-03-16 | 2002-03-14 | Salmonella gallinarum-pullorum attenuated strain and vaccine containing it |
| PL352815A PL202301B1 (pl) | 2001-03-16 | 2002-03-15 | Atenuowany szczep Salmonella gallinarum oraz zawierająca go szczepionka |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI20010555 ITMI20010555A1 (it) | 2001-03-16 | 2001-03-16 | Ceppo attenuato di salmonella gallinarum-pullorum e vaccino che lo contiene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ITMI20010555A1 true ITMI20010555A1 (it) | 2002-09-16 |
Family
ID=11447283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITMI20010555 ITMI20010555A1 (it) | 2001-03-16 | 2001-03-16 | Ceppo attenuato di salmonella gallinarum-pullorum e vaccino che lo contiene |
Country Status (4)
| Country | Link |
|---|---|
| HU (1) | HU226257B1 (enExample) |
| IT (1) | ITMI20010555A1 (enExample) |
| PL (1) | PL202301B1 (enExample) |
| TR (1) | TR200200659A3 (enExample) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2094515C (en) * | 1990-11-01 | 1998-09-01 | Theodore T. Kramer | Bacterial attenuation method and vaccine |
| JP2000502257A (ja) * | 1995-12-19 | 2000-02-29 | アイオワ ステート ユニバーシティー リサーチ ファウンデーション，インコーポレーテッド | ヘテロフィル適合化家禽用ワクチン |
-
2001
- 2001-03-16 IT ITMI20010555 patent/ITMI20010555A1/it unknown
-
2002
- 2002-03-13 TR TR2002/00659A patent/TR200200659A3/tr unknown
- 2002-03-14 HU HU0200984A patent/HU226257B1/hu unknown
- 2002-03-15 PL PL352815A patent/PL202301B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL352815A1 (en) | 2002-09-23 |
| HUP0200984A2 (en) | 2006-12-28 |
| PL202301B1 (pl) | 2009-06-30 |
| HU0200984D0 (enExample) | 2002-05-29 |
| HU226257B1 (en) | 2008-07-28 |
| TR200200659A2 (tr) | 2002-10-21 |
| TR200200659A3 (tr) | 2002-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Whithear et al. | Safety of temperature sensitive mutant Mycoplasma gallisepticum vaccine | |
| Cooper et al. | Vaccination of chickens with a Salmonella enteritidis aroA live oral Salmonella vaccine | |
| Marouf et al. | Inactivated pentavalent vaccine against mycoplasmosis and salmonellosis for chickens | |
| Heddleston et al. | Fowl cholera: immune response in turkeys | |
| Jiang et al. | Live Streptococcus suis type 5 strain XS045 provides cross-protection against infection by strains of types 2 and 9 | |
| Timms et al. | Laboratory and field trial assessment of protection given by a Salmonella Enteritidis PT4 inactivated, adjuvant vaccine | |
| US20210145954A1 (en) | Method of reducing egg contamination | |
| Lublin et al. | Salmonella in Poultry and Other Birds | |
| KR101588297B1 (ko) | 액티노바실루스 플로르뉴모니애, 파스튜렐라 멀토시다 및 써코바이러스에 의한 돼지의 감염을 예방하거나 치료하기 위한 다가 백신 조성물 | |
| AU2004240585B2 (en) | Avian combination-vaccine against E.coli and Salmonella | |
| US20120288523A1 (en) | Administration route for a composition to protect an animal against rhodococcus equi | |
| ITMI20010555A1 (it) | Ceppo attenuato di salmonella gallinarum-pullorum e vaccino che lo contiene | |
| US5641491A (en) | Escherichia coli strain 364 and use of said strain as a vaccine | |
| Keymer et al. | Isolation of Mycoplasma spp. from racing pigeons (Columba livia) | |
| US11541115B2 (en) | Triple vaccine against avibacterium paragallinarum and avian encephalomyelitis virus and fowl pox virus | |
| Jiang et al. | Assessment of 2 Salmonella enterica serovar Typhimurium-based vaccines against necrotic enteritis in reducing colonization of chickens by Salmonella serovars of different serogroups | |
| CA1252721A (en) | Composition for prevention and treatment of mycoplasmal pneumonia | |
| KR101031376B1 (ko) | 살모넬라 엔테리티디스 감염 예방용 불활화 백신 | |
| Hossain et al. | Development of Vaccine for Fish | |
| Khafagy et al. | Preparation and Evaluation of Local Polyvalent Inactivated Salmonella Enterica Serovar Enteritidis, Typhimurium and Kentucky Vaccine for Protection Against Salmonellosis in Chickens in Egypt. | |
| AU2010319678A1 (en) | Actinobacillus suis antigens | |
| Carver et al. | Vaccination with Siderophore receptors and porins protects against fowl cholera challenge by heterologous serotypes | |
| Stewart et al. | Induced resistance to infection of lobsters Homarus americanus by Aerococcus viridans (var.) homari, the bacterium causing gaffkemia | |
| Foster et al. | Oral vaccination with a rough attenuated mutant of S. Infantis increases post-wean weight gain and prevents clinical signs of salmonellosis in S. Typhimurium challenged pigs | |
| US6096322A (en) | Pathogenicity and protective attributes of major clones of Escherichia coli recovered from chickens during processing |